TwinStrand partners with the FNIH in Project for Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
TwinStrand partners with the FNIH in Project for Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
For Research Use Only. Not for use in diagnostic procedures.
©2026 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices